Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 8/2004

01-08-2004

Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma

Authors: Yuichi Nakashima, Takashi Ono, Akira Yamanoi, Osama Nazmy El-Assal, Hitoshi Kohno, Naofumi Nagasue

Published in: Journal of Gastroenterology | Issue 8/2004

Login to get access
Metadata
Title
Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
Authors
Yuichi Nakashima
Takashi Ono
Akira Yamanoi
Osama Nazmy El-Assal
Hitoshi Kohno
Naofumi Nagasue
Publication date
01-08-2004
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 8/2004
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-003-1386-2

Other articles of this Issue 8/2004

Journal of Gastroenterology 8/2004 Go to the issue

Editorial

Why are the results inconsistent on relationships between Se and Le genotypes and continuous infection of H. pylori?

OriginalPaper

The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease

Case report

Primary, solitary, adult T-cell leukemia / lymphoma of the descending colon

Letters to the editor

Video capsule endoscopy for evaluating obscure gastrointestinal bleeding and suspected small-bowel pathology

OriginalPaper

Characteristics of gastric B-cell lymphoma of mucosa-associated lymphoid tissue type involving multiple organs

OriginalPaper

Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits